Ong KL, Stafford LK, McLaughlin SA, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203–34.

Article  Google Scholar 

OECD. The heavy burden of obesity: the economics of prevention [Internet]. Paris: OECD Publishing; 2019.

Book  Google Scholar 

Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis. 2022;18(12):1345–56.

Article  PubMed  Google Scholar 

Nava GL, Asokkumar R, Laster J, et al. Primary obesity surgery endoluminal (POSE-2) procedure for treatment of obesity in clinical practice. Endoscopy. 2021;53(11):1169–73.

Article  Google Scholar 

Jense MT, Hodde T, Palm-Meinders IH, et al. The POSE-2 procedure for people with obesity: a safe and effective treatment option. Obes Surg. 2024;34(10):3686–93.

Article  PubMed  PubMed Central  Google Scholar 

Sullivan S, Kumar N, Edmundowicz SA, et al. ASGE position statement on endoscopic bariatric therapies in clinical practice. Gastrointest Endosc. 2015;82(5):767–72.

Article  PubMed  Google Scholar 

Wilding JP, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989–1002.

Article  PubMed  CAS  Google Scholar 

Younossi ZM, Golabi P, Paik JM, et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335–47.

Article  PubMed  Google Scholar 

Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017;127(1):1–4.

Article  PubMed  PubMed Central  Google Scholar 

Higgins JPT, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5. London: Cochrane; 2024 [cited 2025 Jun 10]. Available from: https://www.training.cochrane.org/handbook

Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.

Article  PubMed  PubMed Central  Google Scholar 

Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.

Article  PubMed  PubMed Central  Google Scholar 

Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute; 2000.

Google Scholar 

Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.

Article  PubMed  PubMed Central  Google Scholar 

Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.

Article  PubMed  PubMed Central  Google Scholar 

Nava GL, Arau RT, Asokkumar R, et al. Prospective multicenter study of the primary obesity surgery endoluminal (POSE 2.0) procedure for treatment of obesity. Clin Gastroenterol Hepatol. 2023;21(1):81–9.

Article  Google Scholar 

AlKhatry M, Rapaka B, Maselli DB, et al. Improvements in hepatic steatosis, obesity, and insulin resistance in adults with nonalcoholic fatty liver disease after the primary obesity surgery endoluminal 2.0 procedure. Endoscopy. 2023;55(11):1028–34.

Article  PubMed  Google Scholar 

Sullivan S, Swain JM, Woodman G, et al. Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: the ESSENTIAL trial. Obesity. 2017;25(2):294–301.

Article  PubMed  Google Scholar 

Miller K, Turró R, Greve JW, et al. Milepost multicenter randomized controlled trial: 12-month weight loss and satiety outcomes after POSE SM vs. medical therapy. Obes Surg. 2017;27(2):310–22.

Article  PubMed  Google Scholar 

Popov VB, Ou A, Schulman AR, et al. The impact of intragastric balloons on obesity-related co-morbidities: a systematic review and meta-analysis. Am J Gastroenterol. 2017;112(3):429–39.

Article  PubMed  Google Scholar 

Qureshi H, Saeed N, Jovani M. Updates in endoscopic bariatric and metabolic therapies. J Clin Med. 2023;12(3):1126.

Article  PubMed  PubMed Central  Google Scholar 

Nakajima K, Suwa K. Excess body weight affects HbA1c progression irrespective of baseline HbA1c levels in Japanese individuals: a longitudinal retrospective study. Endocr Res. 2015;40(2):63–9.

Article  PubMed  CAS  Google Scholar 

Yoon JY, Arau RT. The efficacy and safety of endoscopic sleeve gastroplasty as an alternative to laparoscopic sleeve gastrectomy. Clin Endosc. 2021;54(1):17–24.

Article  PubMed  PubMed Central  Google Scholar 

Kozłowska-Petriczko K, Pawlak KM, Wojciechowska K, et al. The efficacy comparison of endoscopic bariatric therapies: 6-month versus 12-month intragastric balloon versus endoscopic sleeve gastroplasty. Obes Surg. 2023;33(2):498–505.

Article  PubMed  Google Scholar 

Moyad MA. Embracing the pros and cons of the new weight loss medications (semaglutide, tirzepatide, etc.). Curr Urol Rep. 2023;24(11):515–25.

Article  PubMed  Google Scholar